AtriCure highlighted use of its EnCompass system and broader use of its pain treatments, supporting growth. Sales-team spending comes before an anticipated approval, but the expansion plans and long-term profit-margin goal lean positive.
These comments point to more ways to sell AtriCure's devices and a larger sales effort. The caution is that sales spending comes before the anticipated approval, so the benefits are not yet certain.
Follow AtriCure (ATRC) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ATRC